The role of mean platelet volume predicting acute exacerbations of cystic fibrosis in children

Annals of Thoracic Medicine

Volumn 6, Issue 4, 2011, Pages 227-230

  Uysal, Pinar ^a   Tuncel, Tuba ^a   Olmez, Duygu ^a   Babayigit, Arzu ^a   Karaman, Ozkan ^a   Uzuner, Nevin ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Cystic fibrosis; inflammation; mean platelet volume; platelets

Indexed keywords

HEMOGLOBIN;

ARTICLE; BACTERIAL COLONIZATION; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISEASE MARKER; FAILURE TO THRIVE; FEMALE; GENE MUTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; MEAN CORPUSCULAR VOLUME; MEAN PLATELET VOLUME; MEDICAL RECORD REVIEW; ONSET AGE; PREDICTION; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

EID: 80052889979     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.84778     Document Type: Article

References (37)

1. Walters S, Mehta A. Epidemiology of cystic fibrosis. In: Hodson M, Geddes D, Bush A, editors. Cystic Fibrosis. 3 rd ed. London: Hodder Arnold Publishers; 2007. p. 21-80.
2. Kiper N, Yalçín E. Kistik fibrozis. Sürekli Típ Eǧitimi Dergisi 2003;12:131-3.
3. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: Genetic analysis. Science 1989;245:1073-80. (Pubitemid 19231815)
4. Cutting GR, Zeitlin PL. Cystic fibrosis. In: Chernick V, Boat T, Wilmott RW, Bush A, editors. Kendig's Disorders of Respiratory Tract in Children. 7 th ed. Philadelphia: Saunders Publishers; 2006. p. 848-900.
5. Lloyd-Still JD. Pulmonary manifestations. In: Lloyd-Still JD, editor. Textbook of cystic fibrosis. Boston: John Wright Publishers; 1983. p. 165-98.
6. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-82.
7. Ferkol T, Rosenfeld M, Milla CE. Cystic fibrosis pulmonary exacerbations. J Pediatr 2006;148:259-64. (Pubitemid 43286770)
8. Goss CH, Burns JL. Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax 2007;62:360-7. (Pubitemid 46580580)
9. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-905.
10. Mikhailidis DP, Stead RJ, Barradas MA, Hodson ME, Batten JC, Dandona P. Platelet abnormalities in patients with cystic fibrosis and obligate heterozygotes. Haematologica 1990;75:137-40. (Pubitemid 20203575)
11. Permin H, Skov PS, Norn S, Hoiby N, Schiøtz PO. Platelet 3H-serotonin releasing immune complexes induced by Pseudomonas aeruginosa in cystic fibrosis. Allergy 1982;37:93-100. (Pubitemid 12149454)
12. Falco A, Romano M, Lapichino L, Collura M, Davì G. Increased soluble CD40ligand levels in cystic fibrosis. J Thromb Haemost 2004;2:557-60. (Pubitemid 40185678)
13. O'Sullivan BP, Michelson AD. The inflammatory role of platelets in cystic fibrosis. Am J Respir Crit Care Med 2006;173:483-90.
14. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: Its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443-60. (Pubitemid 14243216)
15. Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: Relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 1982;50:509-19. (Pubitemid 12184016)
16. Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate? Hematology 2006;11:317-9. (Pubitemid 46957653)
17. Varol E, Icli A, Ozaydín M, Erdogan D, Arslan A. Mean platelet volume is elevated in patients with myocardial infarction with normal coronary arteries, as in patients with myocardial infarction with obstructive coronary artery disease. Scand J Clin Lab Invest 2009;69:570-4.
18. Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-61. (Pubitemid 26167943)
19. Jindal S, Gupta S, Gupta R, Kakkar A, Singh HV, Gupta K, et al. Platelet indices in diabetes mellitus: Indicators of diabetic microvascular complications. Hematology 2011;16:86-9.
20. Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005;59:981-2.
21. Dani C, Poggi C, Barp J, Berti E, Fontanelli G. Mean platelet volume and risk of bronchopulmonary dysplasia and intraventricular hemorrhage in extremely preterm infants. Am J Perinatol 2011[In Press].
22. Yüksel O, Helvaci K, Basar O, Köklü S, Caner S, Helvaci N, et al. An overlooked indicator of disease activity in ulcerative colitis: Mean platelet volume. Platelets 2009;20:277-81.
23. Makay B, Türkyilmaz Z, Duman M, Unsal E. Mean platelet volume in Henoch-Schönlein purpura: Relationship to gastrointestinal bleeding. Clin Rheumatol 2009;28:1225-8.
24. Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008;75:291-4.
25. Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 2003;22:99-101. (Pubitemid 36748856)
26. Gang N, Drenth JP, Langevitz P, Zemer D, Brezniak N, Pras M et al. Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 1999;26:890-7. (Pubitemid 29195678)
27. Becchi C, Al Malyan M, Fabbri LP, Marsili M, Boddi V, Boncinelli S. Mean platelet volume trend in sepsis: Is it a useful parameter? Minerva Anestesiol 2006;72:749-56. (Pubitemid 44445754)
28. Catal F, Bavbek N, Bayrak O, Uz E, Isik B, Karabel M, et al. Platelet parameters in children with upper urinary tract infection: Is there a specific response? Renal Fail 2008;30:377-81. (Pubitemid 351868681)
29. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, et al. Mean platelet volume: A useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001;96:776-81. (Pubitemid 32240730)
30. Fantini MC, Monteleone G, Macdonald TT. New players in the cytokine orchestra of inflammatory bowel disease. Inflamm Bowel Dis 2007;13:1419-23. (Pubitemid 350206856)
31. van Gameren MM, Willemse PH, Mulder NH, Limburg PC, Groen HJ, Vellenga E, et al. Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 1994;84:1434-41.
32. Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001;98:2720-5.
33. Scheid P, Kempster L, Griesenbach U, Davies JC, Dewar A, Weber PP, et al. Inflammation in cystic fibrosis airways: Relationship to increased bacterial adherence. Eur Respir J 2001;17:27-35. (Pubitemid 32600552)
34. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-905.
35. Brunetti M, Martelli N, Manarini S, Mascetra N, Musiani P, Cerletti C et al. Polymorphonuclear leukocyte apoptosis is inhibited by platelet-released mediators: Role of TGFb-1. Thromb Haemost 2000;84:478-83.
36. O'Sullivan BP, Michelson AD. The inflammatory role of platelets in cystic fibrosis. Am J Respir Crit Care Med 2006;173:483-90.
37. Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 2003;167:1109-12. (Pubitemid 36459657)